Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of GEN2 in Adult Patients With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT06391918 is registered in ClinicalTrials.gov with GenVivo, Inc. as lead sponsor.

NCT NCT06391918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06391918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of GEN2 in Adult Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Lead sponsor
GenVivo, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
March 4, 2024
Completion date
March 1, 2026
Enrollment
37 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult